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Endoscopy plays a key role in the diagnosis and 
treatment in inflammatory bowel disease (IBD). The 
most valuable tool for distinguishing different types of 
IBD is a complete ileocolonoscopy with mucosal 
biopsy. Endoscopic localization of the disease not on-
ly aids in determining prognosis and appropriateness 
of medical therapies but also aids decision-making in 
those undergoing surgical therapy. With regard to 
therapeutic applications, obstructive symptoms caused 
by benign fibrotic strictures can be treated adequately 
by endoscopic balloon dilation. Epidemiological studies 
have demonstrated an increased risk of colorectal 
cancer in patients with both ulcerative colitis and co-
lonic Crohn’s disease (CD). Colonoscopy is currently 
considered to be the gold standard for cancer 
surveillance. Published guidelines recommend that two 
to four biopsy samples should be obtained every 10 
cm in the colorectum, necessitating 20-50 samplings 
per examination. This may result in standard colono-
scopy – which is also very time-consuming and labo-
rious – missing significant numbers of small lesions. 
Various novel techniques have been applied to reduce 
the required number of biopsy samples and the dura-
tion of examinations, including chromoendoscopy with 
or without magnification, fluorescence endoscopy, nar-
row-band imaging, optical coherence tomography, and 
confocal laser endomicroscopy. Until recently the only 
way to evaluate the small-bowel mucosa in a patient 
with CD was by barium small-bowel radiographs and 
intubation of the distal terminal ileum. Both wire-
less-capsule endoscopy (WCE) and double-balloon en-
teroscopy (DBE) allow light to be used in the in-
spection of the small bowel and may replace radio-
logical methods. WCE is more convenient than DBE 
for probing small-bowel mucosal changes, but only 
DBE allows a biopsy sample to be obtained from the 
deep small bowel, and these two examinations can 
be considered complementary. The wider application 
of new techniques in the near future might increase 
the role played by endoscopy in the management of 
IBD. (Gut and Liver 2007;1:118-125)
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INTRODUCTION
  Endoscopy plays a key role in the diagnosis and treat-
ment in inflammatory bowel disease (IBD). Clear-cut in-
dications for endoscopy in IBD are recognized as follows: 
a correct diagnosis, assessment of the disease activity and 
extension, therapeutic implications, and surveillance of 
dysplasia or cancer in patients with long-standing chronic 
colonic IBD.1 Conventional colonoscopy with ileoscopy 
has been regarded as the only endoscopic method and the 
gold standard for IBD evaluation yet. However, the re-
cently developed or developing new technologies can fur-
ther improve colonoscopic diagnosis and treatment. 
Moreover, new endosopic diagnostic tools such as wire-
less capsule endoscoy (WCE) or double balloon entero-
scopy (DBE) have been evolved to evaluate the entire 
small bowel.2 This review will deal with the recent devel-
opment in endoscopic techniques and tools and their up-
dated roles as well as conventional endoscopy in IBD. 
CONVENTIONAL COLONOSCOPY WITH ILEOS-
COPY
1. Diagnosis
  At initial presentation, it is important to make a correct 
diagnosis because treatment strategies differ for two dif-
ferent IBDs, i.e., Crohn's disease (CD) and ulcerative col-
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itis (UC). The single most valuable tool for distinguishing 
the different forms of IBD is a complete ileocolonoscopy. 
In addition to direct inspection of mucosal patterns, mu-
cosal biopsy is a critical component of endoscopic exami-
nation for patients with suspected IBD. Ileocolonoscopy 
was found to be accurate in 80-90% in differentiating UC 
from CD in a prospective study.3
  Challenging and underestimated diagnostic problems 
are diagnosis of indeterminate colitis and differentiation 
of IBD from other intestinal disorders. IBD should be dif-
ferentiated from other ileocolonic diseases resembling 
IBD. Unfortunately, despite careful history taking of pa-
tients even with various endoscopic and histologic find-
ings, in some cases it might be difficult to distinguish en-
teric infections from IBD. In a prospective study inves-
tigating patients with acute mucoid bloody diarrhea, up 
to one third were found to have an infectious etiology.4 
Some of infectious diseases such as Salmonella, Shigella 
or Camphylobacter enterocolitis have endoscopic features 
similar with UC while other infections such as Yersinia 
or Cytomegalovirus (CMV) enterocolitis resemble CD. 
Superimposed infections on IBD by Clostridium difficille or 
CMV, make situations more complicated in some 
instances. Moreover, in endemic areas of tuberculosis, it 
is not an easy task to differentiate between CD and in-
testinal tuberculosis clinically, and somehow, even after 
histopathological examinations despite the fact that some 
of endosocpic characteristics of each disease are typical.5 
For example, direction of ulcer is usually longitudinal in 
CD, whereas transverse in tuberculosis. Sometimes a 
therapeutic trial with anti-tuberculous medications en-
ables differentiation. A recent systematic analysis revealed 
that colonoscopic findings were very useful in the differ-
ential diagnosis between intestinal tuberculosis and CD.6 
In this study, professor Yang's group suggested a scoring 
system for differentiation and demonstrated that anorectal 
lesions, longitudinal as well as aphthous ulcers, and cob-
blestone appearance were parameters favoring CD, while 
localized involvement, patulous ileocecal valve, transverse 
ulcers, and scar or pseudopolyp were parameters favoring 
intestinal tuberculosis. Moreover, clinical features and his-
tological parameters in colonoscopic mucosal biopsy 
specimens may be of value in differentiating between the 
two diseases.7 
  Over the years, use of the term indeterminate or inter-
mediate colitis has broadened to include colonoscopic, ra-
diographic, or histologic appearances that show an over-
lap of diagnostic criteria for UC and CD. Although ileoco-
lonoscopic and histologic evaluation can differentiate be-
tween UC and CD in most cases, approximately 10% of 
patients have indeterminate colitis.8 In this context, radi-
ology, serologic testing (ASCA; anti-Saccharaomyces cer-
evisiae and ANCA; anti-neutrophil cytoplasmic antibody), 
and upper endoscopy combined with random biopsies for 
evaluating granuloma are recommended.9 Although endo-
scopic ultrasonography had been initially recognized to be 
effective in differentiating between CD and UC, it is now 
considered to have a limited function in this setting.10 
Novel diagnostic tools as wells as conventional endoscopy 
are needed to positively identify this group. The role of 
WCE in indeterminate colitis will be discussed later. 
  Because of similar gastrointestinal symptoms and ex-
tra-intestinal manifestations, in addition to the presence 
of intestinal ulcers, differentiation between intestinal 
Behcet's disease and CD might be difficult in some cases. 
Typical endoscopic findings in intestinal Behcet's disease 
which is not a rare disease in Korea include single or a 
few, large, deep, round or oval ulcers with discrete mar-
gin in ileocecal area.11 We have analyzed endoscopic char-
acteristics of both diseases and found that not only in-
volved segments but also several characteristic of ulcers 
including number, shape and depth, are also significantly 
dissimilar between the two diseases. From these findings, 
we have reported that a simple statistical method called 
classification and regression tree is useful for differen-
tiation. By sequential application of two variables, i.e., ul-
cer shape and distribution of lesions, 92% of patients can 
be accurately diagnosed.12 
2. Assessment of extent and severity of disease
  Localization of disease aids in determining prognosis 
and appropriateness of medical therapies and helps to 
stratify risk of colon cancer. Moreover, it can help deci-
sion making in those undergoing surgical therapy. An ac-
curate delineation of the affected location may be im-
portant for planning surgical interventions. However, the 
endoscopic appearance often underestimates the extent of 
disease in UC.13,14 Thus, it is suggested by some authors 
that biopsy specimens should be taken from beyond the 
most proximal extent of endoscopic inflammation to de-
fine the proximal extent of disease.15 With regard to CD, 
the utility of assessing the extent and severity of endo-
scopic disease has remained problematic. In the late 
1980s, GETAID group developed a quantitative endo-
scopic index of severity (CDEIS) by dividing the bowel in 
to 5 segments and generating numeric score based on 
surface involvement by disease and the presence of deep 
or superficial ulcerations.16 However, it was found that 
the endoscopic severity or extent was not correlated with 
Crohn's disease activity index (CDAI).17 
120   Gut and Liver, Vol. 1, No. 2, December 2007
3. Assessment of response to treatments and pre-
diction of relapse
  Clinical remission in active UC is associated with endo-
scopic and histologic remission in about 50-70% of 
patients. However, repeated endoscopy to assess mucosal 
healing generally is not recommended because there are 
few instances in which the endosopic findings would 
change management. Moreover, UC patients often report 
symptom flares after colonoscopy.18 Clinicians should rec-
ognize this side-effect of colonoscopy in patients with 
UC. At present, there are no guidelines on when or how 
often to repeat the endoscopic evaluation in patients with 
improved or quiescent UC.15 However, some of clinical 
trials require endoscopic assessments of severity in UC 
and several endoscopic severity criteria such as Baron 
classification are commonly used.19 
  It is well known that clinical symptoms are not corre-
lated with endoscopic lesions and clinical remission is of-
ten discordant with mucosal healing in CD. In a pro-
spective study assessing the value of colonoscopic mon-
itoring in CD patients that achieved clinical remission 
with prednisolone, only 27% of these patients were in en-
doscopic remission.20 Thus, it was suggested that endo-
scopic monitoring of patients with CD receiving cortico-
steroids is not beneficial. In contrast, a recent trial evalu-
ating the efficacy of infliximab therapy in CD patients 
demonstrated that when significant mucosal healing was 
achieved with infliximab the time to relapse was sig-
nificantly prolonged.21 Endosopic appearances in CD 
might be a better predictor of the future clinical course 
than CDAI. 
  Although endoscopy plays an important role in evaluat-
ing postoperative recurrence in CD patients who have un-
dergone prior bowel resections, routine postoperative en-
doscopic surveillance is often not indicated. 
4. Therapeutic endoscopy for complications of IBD
  Strictures may complicate CD, and to a lesser extent 
UC. Endoscopy is indicated for assessment and biopsy to 
exclude possible malignancy, especially in the setting of 
UC. Obstructive symptoms caused by benign fibrotic 
strictures can be treated adequately by using balloon 
dilation.22,23 Corticosteroid injection into the stricture at 
the time of balloon dilation may improve outcome.24 
Gastrointestinal bleeding is another common complication 
of IBD. However, the presence of an endoscopically treat-
able lesion is uncommon and endoscopy plays more of a 
diagnostic and less of a therapeutic role in the manage-
ment of bleeding. 
5. Surveillance of dysplasia and colorectal cancer
  Epidemiological studies have demonstrated an increased 
risk of colorectal cancer in patients with UC.25 Moreover, 
it has been shown that the risk of cancer in CD involving 
colon is similar to that of UC. In general, there is an in-
creased risk for colorectal cancer associated with younger 
age at onset of IBD, longer duration of colitits, and more 
extensive disease.26 Currently, colonoscopy is considered 
to be the gold standard for surveillance of patients with 
IBD.27 Indications may differ according to the extent and 
duration of disease. Because growth pattern of dysplastic 
lesions in UC is often multifocal and flat, published 
guidelines recommend that 2-4 biopsies should be taken 
every 10 cm in the colorectum, rendering 20-50 biopsies 
per examination. 
  Rubin et al. retrospectively reviewed database of 1339 
surveillance colonoscopies in patients with UC at 
University of Chicago and found that surprisingly almost 
2/3 of neoplastic lesions are visible by white light. 
Because most of neoplastic lesions in UC were endoscopi-
cally visible, they suggested modification of surveillance 
guideline.28 Considering many problems, current recom-
mendation is not only far from perfect and may miss sig-
nificant numbers of small lesions but also very time-con-
suming and laborious. To overcome those problems, there 
have been many efforts to reduce biopsies taken and time 
of examinations through various novel techniques, which 
will be discussed later. Importantly, cancer surveillance in 
IBD patients should be optimally conducted in clinical re-
mitted state to minimize the impact of inflammation on 
the examination.
NEW ENDOSCOPIC TECHNIQUES
1. Chromoendoscopy and magnifying endoscopy
  Chromoendoscopy is a technique in which different 
dyes are topically applied to the gastrointestinal mucosa 
during endoscopy in order to better characterize and 
highlight specific changes in the mucosa.29 Chromoendos-
copy may not only increase the detection of mucosal le-
sions but may also help to predict neoplastic changes 
during the procedure. Endoscopists have mainly used in-
digocarmine and methylene blue and sometimes cresol 
violet for enhancing visualization. Although indigocarmine 
is often used to screen for sporadic adenoma due to con-
venience, methylene blue as an absorptive stain offers ad-
vantages in patients with UC due to its longer stable 
staining pattern. Magnifying endoscopy utilizes a movable 
lens controlled by the endoscopists to vary the degree of 
magnification, which ranges from ×1.5 to ×150.30 The 
Cheon JH, et al: Recent Advances of Endoscopy in Inflammatory Bowel Diseases   121
techniques of chromoendoscopy and magnifying endos-
copy are often used simultaneously to analyze surface 
structure. High resolution and magnification endoscopic 
systems can offer image quality that is significantly better 
than that of conventional endoscopy and have the ability 
to discriminate details. The glandular openings of ad-
enomatous tissues can be seen and differentiated from 
surrounding normal mucosa. In this regard, Kudo et al. 
developed a classification system that divides colorectal 
lesions into 5 categories, which permits a prediction of 
the nature of the detected lesion. Types 1 and 2 are 
staining patterns that predict non-neoplastic lesions, 
whereas types 3 to 5 predict neoplastic lesions.31 Many 
recent investigations have demonstrated the high effi-
ciency of these techniques in detecting early colorectal 
neoplasia.32,33 Moreover, they help to predict neoplastic 
changes during the endoscopic procedure. 
  In IBD settings, these techniques are being under inves-
tigations in two main objectives, i.e., early detection and 
prediction of premalignant lesions and early prediction of 
disease relapse and inflammation in quiescent or re-
mission status. The first randomized controlled trial to 
test whether magnifying chromoendoscopy is capable of 
improving the early detection of intraepithelial neoplasia 
in patients with UC was published by Kiesslich R et al.34 
In their study, significantly more intraepithelial neoplasias 
were detected in the chromoendoscopy group than con-
ventional group (32 vs. 10). These findings were further 
supported by Hurlstone DP et al. Early neoplasia in flat 
mucosal change was observed in 37 lesions, of which 31 
were detected using chromoendoscopy.35 Another trial al-
so suggested that careful mucosal examination aided by 
pancolonic chromoendoscopy and targeted biopsies of 
suspicious lesions might be a more effective surveillance 
methodology than taking multiple non-targeted biopsies.36 
Based on these trials, chromoendoscopy is now in-
corporated into the US guidelines for surveillance in pa-
tients with long-standing UC.37 Concerning the view of 
the prediction of histologic changes in UC, through a 
large prospective study using high-magnification chromo-
scopic colonoscopy, a good correlation was found between 
the Saitoh criteria for magnification imaging and Matts' 
histopathological criteria in patients with UC. Magnifying 
endoscopy was significantly better at predicting the extent 
of disease and histopathological grade than conventional 
endoscopy and the Baron scores of all parameters.38 
Moreover, Nishio et al. investigated the association of pit 
patterns as assessed by magnifying endoscopy with histo-
logical inflammation and mucosal chemokine activity in 
patients with quiescent UC.39 In that study, magnifying 
endoscopic grading was associated the degree of histo-
logical inflammation and mucosal interleukin-8 activity.
2. Fluorescence endoscopy
  Fluorescence endoscopy after 5-ALA sensitization is a 
possible method of visualizing dysplastic lesions in the 
colon that can also be used in patients with UC. By com-
bining fluorescence with red and green reflectance, auto-
fluorescence image (AFI) could be generated. Messmann 
et al. reported that the sensitivity of fluorescence for dys-
plastic lesions was high, ranging from 87% to 100% after 
local sensitization.40 In contrast, because of low frequency 
of dysplasia, recent small-sized trial could not confirm the 
previous data about the efficacy of fluorescence endoscopy 
on the detection of dysplasia in patients with IBD.41 
However, 2 investigations presented in Digestive Disease 
Week 2007 reported that AFI showed the similar de-
tection yield of dysplasia with smaller number of biopsies 
compared with conventional colonoscopy in UC surveil-
lance, suggesting its efficacy.42,43
3. Narrow band imaging (NBI)
  NBI is an innovative optical technology that can provide 
clear imaging of the microvascular structure in the mu-
cosal layer. It illuminates the tissue surface through spe-
cial filters that narrow the red, green, and blue bands 
with increased intensity of the blue band to enhance the 
tissue microvascular structure as a result of the differ-
ential optical absorption of light by hemoglobin.44 The re-
sulting images have the similar appearance of chro-
moendoscopy without dye. It has been reported that NBI 
and chromoendoscopy showed the same sensitivity and 
specificity to differentiate neoplastic from nonneoplastic 
lesions, and both techniques were superior to conven-
tional colonoscopy.45,46 However, in a recent prospective, 
randomized crossover study investigating the patients 
with UC, the sensitivity of the studied first generation 
NBI system was not superior to conventional colonoscopy 
in detecting patients with neoplasia.47 The efficacy of NBI 
system in this setting should be further validated with 
newly introduced system. 
4. Optical coherence tomography (OCT)
  OCT is a new imaging modality, which is similar to 
B-scan ultrasound apart from its image formation, which 
relies on differences in optical (infrared light) rather than 
acoustic backscattering properties of tissue.48 OCT pro-
vides images in real time with a resolution approaching 
that of conventional histopathology, but without the need 
for tissue removal. The spatial resolution of OCT is ap-
proximately 10μm. Firstly, Shen et al. investigated the 
clinical value of optical coherence tomography for differ-
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entiating between CD and UC. The disrupted layered 
structure on OCT, indicating transmural inflammation, 
had diagnostic sensitivity and specificity levels of 90.0% 
and 83.3%, respectively.49 Moreover, in another recent tri-
al, the in vivo OCT correctly detected disease features in 
endoscopically affected colon segments, but even in appa-
rently normal segments of UC patients.50 However, the 
resolution provided by the currently available OCT probes 
is still unsatisfactory. Improvements in both axial and lat-
eral resolution are needed to further refine the diagnostic 
possibilities.
5. Confocal laser endomicroscopy
  Recently, a miniatured confocal microscope integrated 
into the distal tip of a conventional endoscope was 
developed. This new confocal laser endomicroscopy allows 
subsurface analysis of the intestinal mucosa and in vivo 
histologic examination during ongoing endoscopy.51 It has 
been shown that surface and subsurface analysis at cel-
lular and subcellular resolutions can be used to predict 
mucosal neoplasias with high accuracy. However, this 
technique is not suitable for screening of the entire co-
lonic surface in UC to predict neoplasias in flat mucosa 
because of the time required for examination of large sur-
face areas. To overcome this problem, there has been a 
trial using chromoendoscopy-guided endomicroscopy to 
identify potential neoplastic lesions and to diagnose col-
itis-associated mucosal neoplasias in UC.52 It was found 
that 4.75-fold more neoplasias could be detected (p= 
.005) than with conventional colonoscopy, although 50% 
fewer biopsy specimens (p=.008) were required by using 
chromoscopy with endomicroscopy. In addition, endomi-
croscopic analysis was highly sensitive and specific. Thus, 
endomicroscopy based on in vivo histology might de-
termine whether UC lesions identified by chromoscopy 
should undergo biopsy examination, thereby increasing 
the diagnostic yield and reducing the need for biopsy 
examinations. 
  In the near future, these new techniques could be used 
as a multi-modality approach in time and labor effective 
surveillance. For example, fluorescence imaging could be 
used firstly for rapid detection of suspected lesion, fol-
lowed by confocal endomicroscopy for detailed evaluation.
NEW ENDOSCOPIC TOOLS FOR SMALL BO-
WEL EVALUATION
1. Capsule endoscopy
  Until recently the only way to evaluate the small bowel 
mucosa in a patient with CD was by barium small bowel 
radiographs and intubation of the distal terminal ileum. 
WCE is a sensitive way to evaluate the mucosa of the 
small intestine. Many prospective trials, including a multi-
center study conducted by Korean capsule endoscopy 
study group, have shown the superiority of WCE over 
small bowel radiography for the evaluation of small bowel 
lesions.53,54 Moreover, a recent meta-analysis of the yield 
of WCE compared to other diagnostic modalities in pa-
tients with non-stricturing small bowel CD.55 WCE was 
superior to all other modalities for diagnosing non-stric-
turing small bowel CD, with a number needed to test 
(NNT) of 3 to yield one additional diagnosis of CD over 
small bowel barium radiography and NNT of 7 over colo-
noscopy with ileal intubation. Although there remains 
significant uncertainty regarding the role of capsule en-
doscopy in the setting of IBD, WCE is likely to be the 
most objective tool to evaluate the entire small bowel in 
patients who have CD. It is now under investigations to 
evaluate the efficacy of WCE in examining the extent of 
disease, unexplained symptoms, isolated colits, post-
operative recurrence, and mucosal healing.56 For the diag-
nosis of small bowel CD, standardized scoring index is 
necessary and a recently developed scoring index that uti-
lizes parameters consisting of villous edema, ulceration, 
and stenosis is promising.57 Although negative WCE does 
not exclude further diagnosis of CD, WCE might be a po-
tentially clinically useful technique for categorizing a sub-
group of patients with indeterminate colitis. Maunoury et 
al. reported that WCE could display endoscopic features 
suggestive for CD in 5 of 30 patients with indeterminate 
colitis.58 
  There is a controversy concerning the sensitivity of 
WCE in detecting recurrence in the neoterminal ileum.59,60 
Therefore, at present, it seems that WCE cannot replace 
ileocolonoscopy in the regular management of patients af-
ter surgery. 
  However, WCE should be used with caution in the set-
ting of suspected or known CD because of the potential 
for capsule retention. In a retrospective study by Cheifetz 
et al., capsule retention occurred in 13% of patients with 
known CD.61 Capsule retention could cause small bowel 
obstruction and/or lead to a need for surgery to remove 
the capsule in a patient who otherwise might have been 
treated medically. Small bowel radiology can not predict 
capsule retention, while patency capsule made with starch 
may reduce this serious side-effect. 
2. Double balloon endoscopy 
  It is difficult to evaluate mucosal changes in the deep 
small bowel by radiographic examination. Both WCE and 
DBE allow light to be used in the inspection of entire 
small bowel and may replace previous radiological me-
Cheon JH, et al: Recent Advances of Endoscopy in Inflammatory Bowel Diseases   123
thods. WCE is more convenient than DBE for probing 
small bowel mucosal changes, but only DBE allows a bi-
opsy to be obtained, and these two examinations can be 
considered complementary. As expected, Oshtani et al. 
demonstrated superiority of DBE on radiological study in 
detecting minor lesions, such as aphthae, erosions, and 
small ulcers in the ileum.62 DBE also enabled some ther-
apeutic implications such as removal of the retended cap-
sule in the stenosing segment of small bowel. However, 
DBE is a considerably invasive technique that could po-
tentially induce serious complications such as perforation 
or hemorrhage in the setting of small bowel CD. It 
should be further validated for the appropriate selection 
of patients to avoid unnecessary DBE examinations.
CONCLUSION
  The major indications for endoscopy in IBD are to es-
tablish the diagnosis, to differentiate between UC and 
CD, to define the extent and severity of disease activity, 
as well as to diagnose and manage complications. In this 
regard, conventional endoscopy is still essential, but re-
cently developed or developing technologies may provide 
more rapid, more convenient, and more accurate diag-
nosis that leads to proper management.
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